Permethrin (P03AC04)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter KKH) aims to conclude discount contracts pursuant to § 130a paragraph 8 SGB V with all suitable pharmaceutical companies for the active substance (ATC) named under BT-21-Lot and, if applicable, limited to certain dosage forms within the framework of a so-called "open-house procedure." Under the specification of uniform contractual conditions as well as a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the conclusion or accession to a discount contract pursuant to § 130a para. 8 SGB V for the aforementioned active substance. Interested pharmaceutical companies can request the participation documents as well as the contract at the contact address mentioned. A prerequisite for concluding a contract is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. A contract will be concluded with every pharmaceutical company that meets the participation requirements. There is no exclusivity. Accession or contract conclusion can take place at any time and under the same conditions. Individual…

TENDER BRIEF

TENDER DOCUMENTS